F. Muntoni

1.4k total citations
55 papers, 1.0k citations indexed

About

F. Muntoni is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, F. Muntoni has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 18 papers in Genetics and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in F. Muntoni's work include Muscle Physiology and Disorders (23 papers), Neurogenetic and Muscular Disorders Research (18 papers) and Cardiomyopathy and Myosin Studies (12 papers). F. Muntoni is often cited by papers focused on Muscle Physiology and Disorders (23 papers), Neurogenetic and Muscular Disorders Research (18 papers) and Cardiomyopathy and Myosin Studies (12 papers). F. Muntoni collaborates with scholars based in United Kingdom, United States and Italy. F. Muntoni's co-authors include Carlo Cianchetti, Simona Vaccargiu, Maria Giovanna Marrosu, Linda M. Banks, Heinz Jungbluth, J N Fordham, C. M. Boivin, M S Kibirige, Nicola Crabtree and D. J. Chinn and has published in prestigious journals such as Neurology, The American Journal of Human Genetics and European Respiratory Journal.

In The Last Decade

F. Muntoni

51 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Muntoni United Kingdom 17 476 283 161 142 131 55 1.0k
Tiziana Mongini Italy 21 692 1.5× 220 0.8× 294 1.8× 231 1.6× 178 1.4× 74 1.2k
Tina D. Jeppesen Denmark 20 772 1.6× 210 0.7× 131 0.8× 290 2.0× 57 0.4× 40 1.2k
Mette Cathrine Ørngreen Denmark 21 580 1.2× 206 0.7× 135 0.8× 344 2.4× 91 0.7× 52 1.1k
W. Mortier Germany 20 974 2.0× 298 1.1× 135 0.8× 188 1.3× 74 0.6× 54 1.5k
Jack B. Shumate United States 12 532 1.1× 99 0.3× 145 0.9× 116 0.8× 83 0.6× 16 945
G.K. van Wijngaarden Netherlands 17 563 1.2× 222 0.8× 174 1.1× 78 0.5× 76 0.6× 24 959
E. Peter Bosch United States 19 222 0.5× 298 1.1× 54 0.3× 197 1.4× 328 2.5× 35 1.2k
D. C. DeVivo United States 21 961 2.0× 238 0.8× 53 0.3× 365 2.6× 54 0.4× 28 1.6k
Sauson Soldozy United States 16 217 0.5× 112 0.4× 41 0.3× 54 0.4× 278 2.1× 57 968
Carmen Fons Spain 16 235 0.5× 58 0.2× 33 0.2× 123 0.9× 20 0.2× 50 639

Countries citing papers authored by F. Muntoni

Since Specialization
Citations

This map shows the geographic impact of F. Muntoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Muntoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Muntoni more than expected).

Fields of papers citing papers by F. Muntoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Muntoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Muntoni. The network helps show where F. Muntoni may publish in the future.

Co-authorship network of co-authors of F. Muntoni

This figure shows the co-authorship network connecting the top 25 collaborators of F. Muntoni. A scholar is included among the top collaborators of F. Muntoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Muntoni. F. Muntoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Main, Marion, et al.. (2025). Mortality of symptomatic children with spinal muscular atrophy in the era of disease-modifying therapies. Neuromuscular Disorders. 49. 105313–105313.
2.
Coratti, Giorgia, Tina Duong, Matthew Civitello, et al.. (2025). Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review. Neuromuscular Disorders. 49. 105341–105341. 2 indexed citations
3.
4.
Ridout, Deborah, Marina T. DiStefano, Marion Main, et al.. (2020). CONGENITAL MYOPATHIES 2. Neuromuscular Disorders. 30. S74–S75.
5.
Trucco, Federica, et al.. (2019). P.223Respiratory function in SMA type 2 and non-ambulant SMA type 3, longitudinal data from the international SMA consortium (iSMAc). Neuromuscular Disorders. 29. S131–S132. 3 indexed citations
6.
Kiiski, K., Vilma‐Lotta Lehtokari, Adnan Y. Manzur, et al.. (2015). A Large Deletion Affecting TPM3 , Causing Severe Nemaline Myopathy. Journal of Neuromuscular Diseases. 2(4). 433–438. 11 indexed citations
7.
Rahman, Shamima, Yehani Wedatilake, Sebahattin Çirak, et al.. (2013). NDUFA4 Mutations Underlie Dysfunction of a Cytochrome c Oxidase Subunit Linked to Human Neurological Disease (vol 3, pg 1795, 2013). UCL Discovery (University College London). 1 indexed citations
8.
Pane, Marika, Susanna Staccioli, Sonia Messina, et al.. (2008). G.P.4.06 Daily salbutamol in young patients with SMA type II. Neuromuscular Disorders. 18(9-10). 762–762. 2 indexed citations
9.
Zou, Yaqun, Joachim Schessl, Ying Hu, et al.. (2007). C.P.2.04 Skipping of exon 16 in COL6A3 is a recurrent mutation causing severe congenital muscular dystrophy type Ullrich. Neuromuscular Disorders. 17(9-10). 844–844. 1 indexed citations
10.
James, Paul A., M. Zameel Cader, F. Muntoni, et al.. (2006). Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. Neurology. 67(9). 1710–1712. 68 indexed citations
11.
Kinali, Maria, Heinz Jungbluth, L. H. Eunson, et al.. (2004). Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia. Neuromuscular Disorders. 14(10). 689–693. 43 indexed citations
12.
Crabtree, Nicola, M S Kibirige, J N Fordham, et al.. (2004). The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone. 35(4). 965–972. 156 indexed citations
13.
Kristiansen, Marianne, Gun Peggy Knudsen, Scott Tanner, et al.. (2003). X-inactivation patterns in carriers of X-linked myotubular myopathy. Neuromuscular Disorders. 13(6). 468–471. 33 indexed citations
14.
Bonne, Gisèle, Rabah Ben Yaou, L. Demay, et al.. (2002). Clinical analysis of 32 patients carrying R453W LMNA mutation. UCL Discovery (University College London). 2 indexed citations
15.
Rees, Mark I., T. Lewis, Colin D. Ferrie, et al.. (2001). Compound heterozygosity and nonsense mutations in the α1-subunit of the inhibitory glycine receptor in hyperekplexia. Human Genetics. 109(3). 267–270. 64 indexed citations
16.
Laing, Nigel G., Hayley J. Durling, Kathryn N. North, et al.. (2000). Actin and nemaline-related myopathy. UCL Discovery (University College London). 1 indexed citations
17.
Muntoni, F., Caroline A. Sewry, P. Cox, et al.. (1999). Clinical Spectrum and Diagnostic Difficulties of Infantile Ponto-Cerebellar Hypoplasia Type 1. Neuropediatrics. 30(5). 243–248. 17 indexed citations
18.
Marrosu, Maria Giovanna, et al.. (1998). Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology. 50(5). 1397–1401. 126 indexed citations
19.
Marrosu, Maria Giovanna, et al.. (1997). A novel point mutation in the peripheral myelin protein 22 (PMP22) gene associated with Charcot-Marie-Tooth disease type 1A. Neurology. 48(2). 489–493. 19 indexed citations
20.
Theodosiou, Aspasia, Nanda R. Rodrigues, Kevin Talbot, et al.. (1995). MOLECULAR ANALYSIS OF CHILDHOOD-ONSET SPINAL MUSCULAR-ATROPHY. The American Journal of Human Genetics. 57. 106–106. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tiziana Mongini Breakdown of academic impact, for papers by Tina D. Jeppesen Breakdown of academic impact, for papers by Mette Cathrine Ørngreen Breakdown of academic impact, for papers by W. Mortier Breakdown of academic impact, for papers by Jack B. Shumate Breakdown of academic impact, for papers by G.K. van Wijngaarden Breakdown of academic impact, for papers by E. Peter Bosch Breakdown of academic impact, for papers by D. C. DeVivo Breakdown of academic impact, for papers by Sauson Soldozy Breakdown of academic impact, for papers by Carmen Fons
Rankless by CCL
2026